Physician profile
Thomas N Epperson
NPI 1184605966
$2,183.17
in general payments reported to CMS, 2019-2025
16 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $518 · 2021: $441 · 2022: $131 · 2023: $152 · 2024: $141 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $523.27 | 2019-2023 | Jardiance, Tradjenta |
| Glaxosmithkline, LLC. | $356.33 | 2019-2024 | Trelegy Ellipta |
| Amarin Pharma, INC. | $331.72 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $242.73 | 2019-2024 | Farxiga |
| Pfizer INC. | $229.28 | 2019-2021 | |
| Lilly USA, LLC | $181.63 | 2019-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $73.89 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Exact Sciences Corporation | $44.53 | 2025 | Cologuard Collection Kit |
| Vertex Pharmaceuticals Incorporated | $41.10 | 2025 | |
| Merck Sharp & Dohme LLC | $39.62 | 2019-2020 | |
| Medtronic, INC. | $34.55 | 2023 | Minimed 770g, Minimed 780g |
| Abbvie INC. | $18.41 | 2024 | |
| Polynovo North America LLC | $17.82 | 2024 | Novosorb Btm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.56 | 2024 | Lifevest |
| Corcept Therapeutics | $16.77 | 2025 | Korlym |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $13.96 | 2024 | Elfabrio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Epperson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.